Table 2.
Biochemical results of the patient and control group.
| AS (n = 42) | Control (n = 42) | P value | |
|---|---|---|---|
| Visfatin (ng/mL) | 3.5 (0.19–19.3) | 1.3 (0.17–7.0) | <0.001 |
| FMD (%) | 7.2 ± 2.8 | 8.7 ± 1.7 | 0.007 |
| cIMT mm | 0.50 ± 0.1 | 0.44 ± 0.1 | 0.003 |
| Carotid plaque (n) | 0 | 0 | 1.000 |
| FPG (mg/dL) | 99.6 ± 22.3 | 93.4 ± 16.1 | 0.144 |
| BUN (mg/dL) | 25.8 ± 7.5 | 29.9 ± 8.2 | 0.020 |
| Creatinine (mg/dL) | 0.7 ± 0.08 | 0.7 ± 0.18 | 0.106 |
| AST (IU/L) | 22.0 ± 11.9 | 22.8 ± 10.2 | 0.733 |
| ALT (IU/L) | 27.4 ± 18.7 | 24.8 ± 16.3 | 0.502 |
| SUA (mg/dL) | 4.3 ± 0.9 | 3.3 ± 0.6 | <0.001 |
| CRP (mg/dL) | 0.20 (0.10–4.82) | 0.10 (0.10–2.15) | 0.008 |
| ESR (mm/h) | 23.2 ± 17.5 | 14.7 ± 11.3 | 0.007 |
| WBC (×109/L) | 7.5 ± 2.0 | 7.2 ± 1.4 | 0.463 |
| Hb (g/dL) | 13.5 ± 1.9 | 13.3 ± 1.3 | 0.668 |
| TSH (mIU/L) | 1.7 ± 0.9 | 1.8 ± 1.1 | 0.788 |
| TC (mg/dL) | 191.3 ± 39.7 | 199.8 ± 25.2 | 0.250 |
| TG (mg/dL) | 131.9 ± 52.5 | 128.8 ± 53.7 | 0.792 |
| HDL (mg/dL) | 40.2 ± 8.6 | 48.3 ± 9.8 | <0.001 |
| LDL (mg/dL) | 124.7 ± 35.6 | 125.7 ± 19.8 | 0.883 |
Abbreviations: AS, ankylosing spondylitis; FMD, flow-mediated dilation; cIMT, carotid intima-media thickness; FPG, fasting plasma glucose; BUN, blood urea nitrogen; AST, aspartate aminotransferase; ALT, alanine aminotransferase; SUA, serum uric acid; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; WBC, white blood cell count; Hb, hemoglobin; TSH, thyroid stimulating hormone; TC, total cholesterol; TG, triglyceride; HDL, high-density lipoprotein; LDL, low-density lipoprotein.